Evidence map›Paper›PMID 22319659›Full record

ArticleSpermatogenesis2011

Testosterone signaling and the regulation of spermatogenesis.

William H Walker

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Spermatogenesis, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 145 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed, 2 pooled it
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04439799 phase4completednot on this mapstarted 2020, after this paper: background citation

A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections: A Phase IV, Prospective, Randomized, Non-Blinded, Multi-Institutional Study

TypeinterventionalSponsorUniversity of MiamiRan2020 to 2023Enrolled81ConditionsHypogonadism, MaleArmsTestosterone Cypionate 200 Mg/ML, Intranasal Testosterone
NCT04523480 phase3completednot on this mapstarted 2020, after this paper: background citation

Randomized Control Trial of Long Acting Subcutaneous Testosterone Pellets for Hypogonadism: Testopel ® vs. Generic Testosterone Pellets.

TypeinterventionalSponsorUniversity of MiamiRan2020 to 2022Enrolled75ConditionsHypogonadismArmsTestopel 75mg Drug Implant, Testopel 100mg Drug Implant, Testopel 200mg Drug Implant
3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 2 syntheses or guidelines pooled it, 392 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

William H WalkerCenter for Research in Reproductive Physiology; Department of Obstetrics, Gynecology and Reproduction Sciences; Magee Women's Research Institute; University of Pittsburgh; Pittsburgh, PA USA.
Pittsburg State University · US

Funding

Nongenomic Androgen Signaling in Sertolli CellsR01HD043143 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WALKER, WILLIAM H · 2003 to 2010
$1.8M
NICHD NIH HHS R01 HD043143
6 · The paper itself

Abstract

Spermatogenesis and male fertility are dependent upon the presence of testosterone in the testis. In the absence of testosterone or the androgen receptor, spermatogenesis does not proceed beyond the meiosis stage. The major cellular target and translator of testosterone signals to developing germ cells is the Sertoli cell. In the Sertoli cell, testosterone signals can be translated directly to changes in gene expression (the classical pathway) or testosterone can activate kinases that may regulate processes required to maintain spermatogenesis (the non-classical pathway). Contributions of the classical and non-classical testosterone signaling pathways to the maintenance of spermatogenesis are discussed. Studies that may further elaborate the mechanisms by with the pathways support spermatogenesis are proposed.

Identifiers

PMID22319659
PMCPMC3271653
OpenAlexW2154831045

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.